3. Definition
“It is defined as implantation of fertilized ovum at a site
other than uterine endometrium”
Etiology
Delay in the ovum transport.
4. Risk Factors
•Previous history of tubal pregnancy
•Previous tubal surgery
•PID
•Termination of pregnancy
•IUCD Use
•Assisted Conception
•Smoking
•DES
•Salpingitis
5. Pathophysiology
“Abnormality in either tubal morphology or function”
•Damage to tubal mucosa
•Dysfunction of myoelectrical activity
•Dysfunction of cilia
Incidence
11.1% in 1000 pregnancies in UK
9. Diagnosis
Diagnosis is made upon
•History
•Examination
•Complete Workup
On History
Classical alarming triad
•Amenorrhea
•Abd Pain
•Abnormal Uterine Bleeding
10. On Examination
Hemodynamically Stable
Hemodynamically Unstable
On P/A
•Generalized Tenderness
•Localized Tenderness
•Rebound Tenderness
Cullen’s Sign
13. Biochemical
•Beta HCG
•Serum Progesterone
Beta HCG
•Secreted by syncitiotrophoblast
Normal Doubling Time
•2.2 days
Normal Half Life
•32 – 37hrs
14. RCOG Says
“An increase in BETA HCG of < 66% over 48hrs means
ectopic pregnancy”
ACOG Says
“An increase in BETA HCG of < 53% over 48hrs means
ectopic pregnancy”
15. Serum Progesterone
•C21 Compound
•Useful in diagnosis and management of pregnancy
of unknown location
Progesterone Levels
>60 nmol / L Viable IUP
<20 nmol / L Failing PUL
21. Criteria
•Clinically stable asymptomatic woman.
•B HCG conc <1000-2000 1U/L
•Haemo peritoneum of < 50- 100 ml
•Adnexal mass of < 2cm
•Absent FCA or fetal parts
Disadvantage
Morbidity
•Need of MX
•Need of surgery
Mortality
• Rupture
22. Medical Management
Methotrexate
•Offered to the patient desiring to retain fertility in presence
of contralateral tube damage.
•Antimetabolite Folic Acid Antagonist (Inhibits DNA synthesis
in rapidly dividing cells)
Side Effects
• GIT
• Skin and Hair
• Renal Toxicity
• Myelo Suppression
Criteria of Patient Selection
• Initial BHCG < 3000 iu / L
•Adnexal mass < 2cm
•Absent FCA
23. Pre Requisite Investigations for MTX
• CBC and platelets
• LFT’s & RFT’s
Routes
• Systemic
• Local
Routes
• Single standard dose protocol
• Multiple fixed dose protocol
Mifepristone & MTX Combination
24. Day Single Dose Multiple Dose
1 HCG Conc.
MTX 50 mg/m2 body surface area i/m
HCG Conc.
MTX 1mg/kg body wt i/m
2 Folinic acid .1mg/kg body wt po
3 HCG Conc
If <15% ↓ from day 1-3, Give MTX 1mg/kg i/m
If ≥ 15% decline from day 1-3, begin weekly HCG
4 HCG protocols vary Folinic acid .1mg/kg body wt po
5 HCG Conc
If <15% ↓ from day 3-5, Give MTX 1mg/kg i/m
If ≥ 15% ↓from day 3-5, ,begin weekly HCG
6 Folinic acid .1mg/kg body wt po
7 HCG Conc
If <15% ↓ HCG from day 4-7
Or <25% ↓ HCG from day 1-7
Additional dose of MTX 50mg/m2 i/m
If ≥ 15% ↓from day 4-7
If ≥ 25% ↓from day 1-7
Draw HCG conc. Weekly until HCG is undetectable.
HCG Conc
If <15% ↓ from day 5-7, Give MTX 1mg/kg i/m
If ≥ 15% ↓from day 5-7, ,begin weekly HCG
8 Folinic acid .1mg/kg body wt po
14 HCG Conc
If <15% ↓ hcg from day 7-14
Additional dose of MTX 50mg/m2 i/m
If ≥ 15% ↓ from day 7 - 14 check HCG weekly untill
undetectable
HCG Conc
If <15% ↓ hcg from day 7-14
Additional dose of MTX 1mg/kg i/m
If ≥ 15% ↓ from day 7 - 14 check HCG weekly untill
undetectable
15 Folinic acid .1mg/kg body wt po
21-28 If 3 doses given and there is 15% decline from day
21-28 proceed with laparoscopic surgery
If 5 doses have been given and there is< 15% decline
from day 14-21 proceed with laparoscopic surgery
25. Surgical
• Laparoscopy
• Laparotomy
Selection Criteria
• Hemodynamic condition of patient.
• Size and location of pregnancy
• Expense of surgery
• Availability of instruments
Conservative Surgery Salpingotomy
Radical Salpingectomy
27. Laparoscopic salpingtomy
Considered primary Rx of tubal Ectopic if contra lateral tube
damage is there and patient wants to retain fertility.
Disadvantages
• Retention of troproblastic tissue and need if MTX
35. PT +ve + Suspected Eptopic
TVS
IUP Ectopic seen USG inconclusive
Stable
Unstable
Surgical
Expectant Medical Surgical
Follow up
BHCG BHCG
Serial BHCG
Till 20iu / L
> 15 Fall of
BHCG on
Day 4 - 7
< 15 Fall of
BHCG on
Day 4 - 7
BHCG on
Day 4 - 7
Repeat BHCG
serially
Consider 2nd dose Surgical
Management
36. PT +ve + Suspected Ectopic
TVS
PUL
Stable Unstable
OPD Management BHCG Levels
Inpatient Management
>66% Inc in BHCG in 48hrs < 66% Inc in BHCG in 48hrs >15% dec in BHCG in 48hrs
or < 15% dec in BHCG in 48hrs
IUP Seen Ectopic Seen + Stable Patient
Rescan after one week
IUP Confirmed Ectopic Confirmed PUL
Rescan for Viability Manage as indicated Repeat BHCG
Failing PUL
Repeat BHCG
Serial BHCG till < 20 iu / L